# Seraplex Inc – FDA Inspection, Mar 8, 2024

Source: https://www.keypedia.com/records/fda_inspections/seraplex-inc/c0111a88-9540-4b48-8dbb-22b53fd4a678
Source feed: FDA_Inspections

> FDA inspection 1232805 of Seraplex Inc, March 08, 2024. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1232805
- Company Name: Seraplex Inc
- Inspection Date: 2024-03-08
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1084988 - 2019-03-22
- FDA Inspection 792878 - 2012-07-25

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/dylan-r-jock/a083cb5e-95d7-491d-9c6d-8c36c5963ddf)
- [Eric Zhu](https://www.keypedia.com/people/eric-zhu/32919a8f-841a-441b-a489-8495f2e16993)

Company: https://www.keypedia.com/companies/seraplex-inc/bf5f27b4-6fb3-4639-925e-2f5a67c2c23a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d